论文部分内容阅读
宫颈癌治愈率的提高取决于早期治疗,Ⅰ、Ⅱ期治愈率已有进一步改善,但Ⅲ、Ⅳ期的治疗尚无进展.宫颈癌早期病例的治疗选择是根据肿瘤对放射试验剂量的敏感性、肿瘤的恶性度,患者年龄和全身情况.晚期病例的淋巴结转移发生率高,尤其是有的部位至今尚无治愈方法,因此晚期病例,既使肿瘤对放射敏感也难免死亡.因为远处淋巴结转移的治疗不论是根治性手术或放疗均可发生并发症,故不能提高治愈率,此组病人不能以局部或区域性治疗达到治愈,而需要进行全身性的化疗或免疫治疗.尽管细胞毒素类药物的应用已有15年多,但在宫颈癌治疗中化疗很少试用,因大多数药物对鳞癌无效.况且既往作过广泛手术和/或放疗的宫
The cure rate of cervical cancer depends on the early treatment, the cure rate of stage Ⅰ and Ⅱ has been further improved, but there is no progress in the treatment of stage Ⅲ and Ⅳ. The treatment options for early stage cervical cancer are based on the tumor sensitivity to radiation test dose , The malignancy of the tumor, the age of the patient and the general condition.The incidence of lymph node metastasis in advanced cases is high, especially in some parts of the disease so far there is no cure, so even if the tumor is sensitive to radiation is also inevitable death of the tumor because distant lymph nodes Metastasis treatment Radical surgery or radiotherapy can occur complications, it can not improve the cure rate, this group of patients can not be treated with local or regional treatment, and the need for systemic chemotherapy or immunotherapy .Although cytotoxins More than 15 years have passed since the drug was introduced, but chemotherapy is rarely used in cervical cancer because most drugs are ineffective against squamous cell carcinoma, and in the past, extensive surgery and / or radiotherapy